Trial intelligence / Profile preview

Phase III trial of Tanreqing oral liquid for acute tracheobronchitis

CTR20190318Phase 3Suspended

Sponsor
Henan Xinyi Pharmaceutical
Start
Nov 2020
Countries
1
01

Overview

A Phase 3 trial of tanreqing in acute bronchitis, sponsored by Henan Xinyi Pharmaceutical. Started Nov 2020; status: suspended.

02

Drugs

tanreqing
03

Conditions

acute bronchitis

Beyond the preview

Go deeper on CTR20190318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20190318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call